CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 01, 2014	Mar. 02, 2013	Mar. 03, 2012
OPERATING ACTIVITIES:
Net income	$ 75,052	$ 69,181	$ 84,804
Adjustments to reconcile net income to net cash provided by operating activities:
Impairment charges	2,054	5,593	974
Depreciation and amortization	34,964	31,182	27,027
Deferred income taxes	10,143	5,041	10,805
Loss on disposals of property and equipment	1,448	1,250	1,528
Gain on sale of investment	(2,076)	0	0
Share-based compensation	7,068	6,612	5,187
Excess tax benefits from share-based compensation	(2,897)	(2,963)	(5,951)
Changes in operating assets and liabilities:
Accounts receivable, net	(1,189)	(5,710)	1,511
Merchandise inventories, net	(56,707)	(22,403)	(23,880)
Other assets	(13,204)	9,342	(8,645)
Accounts payable	43,315	(2,471)	(7,512)
Employee compensation	8,690	(6,843)	3,887
Income taxes payable	6,248	(6,850)	8,971
Other liabilities and accrued expenses	5,632	914	2,950
Deferred credits from landlords	443	(382)	(6,916)
Net cash provided by operating activities	118,984	81,493	94,740
INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(81,668)	(81,586)	(29,131)
Acquisitions, net of cash acquired	(12,687)	(3,526)	(8,495)
Payments for intangible assets	0	0	(550)
Proceeds from disposals of property and equipment	62	77	40
Cash paid for investment	0	(1,000)	0
Proceeds from sale of investment	3,076	0	0
Net cash used in investing activities	(91,217)	(86,035)	(38,136)
FINANCING ACTIVITIES:
Dividends paid to shareholders	(13,674)	(12,147)	(10,512)
Proceeds from issuance of common stock	7,725	4,422	16,496
Excess tax benefits from share-based compensation	2,897	2,963	5,951
Purchase of treasury stock	(22,618)	(77,208)	(60,368)
Funding of related-party note receivable	0	(4,000)	0
Proceeds from sale of redeemable noncontrolling interest	0	10,000	0
Net cash used in financing activities	(25,670)	(75,970)	(48,433)
Net increase (decrease) in cash and cash equivalents	2,097	(80,512)	8,171
Cash and cash equivalents at beginning of year	226,982	307,494	299,323
Cash and cash equivalents at end of year	229,079	226,982	307,494
Supplemental disclosure of noncash operating and investing activities:
Capital expenditures incurred but not yet paid	$ 9,200	$ 9,715	$ 0